SMA News Today

AveXis Now Known as Novartis Gene Therapies, Focus of Continuing Work

AveXis Now Known as Novartis Gene Therapies, Focus of Continuing Work

SMA News Today’s multimedia associate, Price Wooldridge, discusses AveXis, now known as Novartis Gene Therapies, focusing on continued work with genetic diseases. Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

Duration: 4 min

Release Date:

Share part or all of the audio of this episode